In the last 12 mths, we've had some very good news that could...

In the last 12 mths, we've had some very good news that could prove to be a huge catalyst for share price APRECIATION in the next 12 mths, we are DUE for a BROKER upgrade which I'm sure every TZL'er is very excited about.
L12 mths news at no particular order:

(1) Litigation with Zigalla/BZI settled with an unknown payment about to be received by TZ
(2) Aero Asset Maintainability website up and running with a deal being worked on by Management
(3) PAD being trialed by a Major Australian Integrated Logistics Provider
(4) IXP chosen by Fortune 100 company (a World Leader in Data Management and Strategic sourcing) for Trial
(5) PAD Deployment to two MAJOR US Corporates and BEAR River MOU for TZ Courier
(6) TZ Ready Cabinet Program launched with a Global Data Centre Manufacturer.
(7) A successful trial with The Sterling which eventuated to a 10 year lease for TZ Concierge
(8) PAD Supplier Distribution Agreement with Pitney Bowes
(9) IXP Supplier Distribution Agreement with Anixter
(10) A 3 for 1 capital raising @ 35 cents which raised $9M of working capital. This also means that 75% of shares was trading well above the $1 mark when not many i's and t's were crossed off.

Now were at a more financially stable and more advanced product development stage 33 cents seem so CHEAP, this could explain the increased interest we've been getting from a someone or some group....TZ the sleeping giant could soon awaken...can't wait for the next 12 mths to fly...

Pattersons had a 12 month price target of AUD$0.84 back in Nov 2010. I wonder how close they'll get?
PDT alone had a FY Revenue of over $21M which is an all time high.

From Pattersons:

TZ has provided an update of its 1Q11 trading results and current sales
opportunities which are emerging. The company reported 1Q11 sales
of US$4.8 million, exceeding internal expectations by c16%, and that
underlying operating costs were less than expected.
The PDT division (design and engineering outsourcing) continued its
solid performance with sales exceeding expectations by 21% and
margins steady. The strong 1Q11 result was predominantly driven by
customers in the medical sector. TZ expects the robust demand to
continue as a result of continued targeted sales and marketing efforts
to customers in the healthcare, defence and consumer goods sectors.
The TZI division (commercialising TZ?s IP) only achieved 79% of its
revenue target due to delays in long lead-time electronic components
deferring several booked order shipments into 2Q11. TZ indicated that
the inventory stockouts were indicative of general low inventory levels
globally and not specific to its components. It is worth noting that if
orders booked during 1Q11 were able to be processed and delivered,
the division would have exceeded its revenue target by 20%.
TZI?s strong sales orders were driven by demand for Infrastructure
Protection products substantially exceeding expectations. These
products provide data centres with micro-security and audit capability
at a data cabinet level. This helped to offset order delays in Packaged
Asset Delivery (PAD) with several project timelines pushing out into
late 2Q11. However, the company indicated that a substantially strong
pipeline had emerged in PAD with one proposal under consideration
having the potential to exceed the FY11 PAD revenue target on its own.
TZI has also started to increase its sales force with the addition of four
new sales resources this month to substantially increase its US sales
coverage and support sales generation in 2H11. The Infrastructure
Protection business unit has also been actively engaged with Anixter
sales resources in Latin America, Europe, Asia and Australia to drive a
coordinated sales approach into these markets.
We expect positive sales updates and meeting FY11 guidance to be the
key catalysts for gaining market credibility and being positively rerated. Our 12-month price target is unchanged at $0.84 per share
which implies a market capitalisation of c$60 million. We believe this is
justified given the company has invested cUS$30 million in IP and its
products are now being globally launched by NYSE-listed partners. We
are forecasting a 12-month return of 73% and maintain our
Speculative Buy recommendation.